Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth
- PMID: 21457568
- PMCID: PMC3080330
- DOI: 10.1186/1756-9966-30-35
Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth
Abstract
Background: Iodine 125 (125I) seed irradiation is an effective treatment for unresectable pancreatic cancers. However, the radiobiological mechanisms underlying brachytherapy remain unclear. Therefore, we investigated the influence of continuous and low-energy 125I irradiation on apoptosis, expression of DNA methyltransferases (DNMTs) and cell growth in pancreatic cancers.
Materials and methods: For in vitro 125I seed irradiation, SW-1990 cells were divided into three groups: control (0 Gy), 2 Gy, and 4 Gy. To create an animal model of pancreatic cancer, the SW 1990 cells were surgically implanted into the mouse pancreas. At 10 d post-implantation, the 30 mice with pancreatic cancer underwent 125I seed implantation and were separated into three groups: 0 Gy, 2 Gy, and 4 Gy group. At 48 or 72 h after irradiation, apoptosis was detected by flow cytometry; changes in DNMTs mRNA and protein expression were assessed by real-time PCR and western blotting analysis, respectively. At 28 d after 125I seed implantation, in vivo apoptosis was evaluated with TUNEL staining, while DNMTs protein expression was detected with immunohistochemical staining. The tumor volume was measured 0 and 28 d after 125I seed implantation.
Results: 125I seed irradiation induced significant apoptosis, especially at 4 Gy. DNMT1 and DNMT3b mRNA and protein expression were substantially higher in the 2 Gy group than in the control group. Conversely, the 4 Gy cell group exhibited significantly decreased DNMT3b mRNA and protein expression relative to the control group. There were substantially more TUNEL positive in the 125I seed implantation treatment group than in the control group, especially at 4 Gy. The 4 Gy seed implantation group showed weaker staining for DNMT1 and DNMT3b protein relative to the control group. Consequently, 125I seed implantation inhibited cancer growth and reduced cancer volume.
Conclusion: 125I seed implantation kills pancreatic cancer cells, especially at 4 Gy. 125I-induced apoptosis and changes in DNMT1 and DNMT3b expression suggest potential mechanisms underlying effective brachytherapy.
Figures








Similar articles
-
Effect of brachytherapy on NF-κB and VEGF in gastric carcinoma xenografts.Oncol Rep. 2014 Aug;32(2):635-40. doi: 10.3892/or.2014.3255. Epub 2014 Jun 12. Oncol Rep. 2014. PMID: 24926530
-
Synergistic Effects of 125I Seed Implantation Brachytherapy and Gemcitabine in Pancreatic Tumors.Discov Med. 2024 Jul;36(186):1464-1476. doi: 10.24976/Discov.Med.202436186.136. Discov Med. 2024. PMID: 39054717
-
The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells.J Exp Clin Cancer Res. 2009 Jan 29;28(1):12. doi: 10.1186/1756-9966-28-12. J Exp Clin Cancer Res. 2009. PMID: 19175942 Free PMC article.
-
Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds.World J Gastroenterol. 2015 Feb 28;21(8):2336-42. doi: 10.3748/wjg.v21.i8.2336. World J Gastroenterol. 2015. PMID: 25741139 Free PMC article.
-
A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers.Int J Radiat Biol. 2020 Mar;96(3):383-389. doi: 10.1080/09553002.2020.1704300. Epub 2020 Jan 24. Int J Radiat Biol. 2020. PMID: 31977258 Review.
Cited by
-
125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts.Radiat Oncol. 2020 Oct 15;15(1):238. doi: 10.1186/s13014-020-01682-5. Radiat Oncol. 2020. PMID: 33059701 Free PMC article.
-
Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer.World J Gastroenterol. 2018 Dec 14;24(46):5280-5287. doi: 10.3748/wjg.v24.i46.5280. World J Gastroenterol. 2018. PMID: 30581276 Free PMC article.
-
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.World J Gastrointest Oncol. 2016 Feb 15;8(2):165-72. doi: 10.4251/wjgo.v8.i2.165. World J Gastrointest Oncol. 2016. PMID: 26909131 Free PMC article. Review.
-
Evaluation of Iodine-125 Interstitial Brachytherapy Using Micro-Positron Emission Tomography/Computed Tomography with 18F-Fluorodeoxyglucose in Hepatocellular Carcinoma HepG2 Xenografts.Med Sci Monit. 2019 Jan 12;25:371-380. doi: 10.12659/MSM.912590. Med Sci Monit. 2019. PMID: 30636171 Free PMC article.
-
Efficacy and safety of 3D printing coplanar template-assisted iodine-125 seed implantation as palliative treatment for inoperable pancreatic cancer.J Contemp Brachytherapy. 2022 Apr;14(2):140-147. doi: 10.5114/jcb.2022.114990. Epub 2022 Mar 28. J Contemp Brachytherapy. 2022. PMID: 35494180 Free PMC article.
References
-
- Ducreux M, Boige V, Malka D. Treatment of advanced pancreatic cancer. Semin Oncol. 2007;34:S25–30. - PubMed
-
- Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485–492. - PubMed
-
- Tanaka M. Important clues to the diagnosis of pancreatic cancer. Rocz Akad Med Bialymst. 2005;50:69–72. - PubMed
-
- Cohen SJ, Dobelbower R Jr, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys. 2005;62:1345–1350. - PubMed
-
- Liu Y, Liu JL, Cai ZZ, Lu Z, Dong YH, Li ZS, Gong YF, Man XH. A novel approach for treatment of unresectable pancreatic cancer: design of radioactive stents and trial studies on normal pigs. Clin Cancer Res. 2007;13:3326–3332. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical